Antibacterial activity of the human host defence peptide LL-37 and selected synthetic cationic lipids against bacteria associated with oral and upper respiratory tract infections.
about
Potential Use of Antimicrobial Peptides as Vaginal Spermicides/MicrobicidesHigh-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.Antimicrobial ceragenins inhibit biofilms and affect mammalian cell viability and migration in vitro.Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13.New insights into the antimicrobial effect of mast cells against Enterococcus faecalisMagnetic nanoparticles enhance the anticancer activity of cathelicidin LL-37 peptide against colon cancer cellsCandidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites.Bactericidal Activity of Ceragenin CSA-13 in Cell Culture and in an Animal Model of Peritoneal Infection.The Role of Cathelicidin LL-37 in Cancer Development.Identification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infectionCore-shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins.Sporicidal activity of ceragenin CSA-13 against Bacillus subtilis.LEAP-2, LL-37 and RNase7 in tonsillar tissue: downregulated expression in seasonal allergic rhinitis.Ceragenin CSA-13 as free molecules and attached to magnetic nanoparticle surfaces induce caspase-dependent apoptosis in human breast cancer cells via disruption of cell oxidative balance.Photodynamic Action of LED-Activated Curcumin againstStaphylococcus aureusInvolving Intracellular ROS Increase and Membrane Damage
P2860
Q26765450-A718D86D-AC6D-42FC-8FE4-E626274CA9D0Q27692605-7A96A0E7-67B1-4499-83A6-F4ACE4EBD453Q33863001-DCEB9ED3-B682-4FC8-9C0A-A4F46AE66A0FQ33870762-B40D3C38-C3D2-470A-A03A-AD5C3E5873CBQ34596183-005A1A38-1943-4D20-9F7E-3CCA22239F03Q35703756-88C256ED-BA4C-457B-A6DB-4A40EB6C1554Q36055572-8B5968E9-FCE3-4EBC-AE60-B06FACEC7F48Q36076086-68E490BA-3CDD-4D8A-ABA9-BFCB9B6AE3E9Q36465085-0BDE2F40-AE35-480B-A143-EB9FB54B3DADQ37036638-3DA4D05C-7360-47F2-B577-DFDA8855229EQ37361845-39A1F61D-A346-4B10-83C2-73FFC48343A1Q37704569-2664D038-CBA8-45F2-A59C-BFDAE94248C4Q42219114-0C72D4BF-49F2-4A97-A905-E41949078845Q55255494-9C085FE5-6069-4202-9A70-22D9BB1DCD94Q59045815-CA4F105C-610A-49EF-B302-CEFB43D26A84
P2860
Antibacterial activity of the human host defence peptide LL-37 and selected synthetic cationic lipids against bacteria associated with oral and upper respiratory tract infections.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Antibacterial activity of the ...... respiratory tract infections.
@en
Antibacterial activity of the ...... respiratory tract infections.
@nl
type
label
Antibacterial activity of the ...... respiratory tract infections.
@en
Antibacterial activity of the ...... respiratory tract infections.
@nl
prefLabel
Antibacterial activity of the ...... respiratory tract infections.
@en
Antibacterial activity of the ...... respiratory tract infections.
@nl
P2093
P2860
P356
P1476
Antibacterial activity of the ...... respiratory tract infections.
@en
P2093
Christopher A McCulloch
David E Fein
Dorota Namiot
Fitzroy J Byfield
Katarzyna Leszczynska
Katrina Cruz
Paul A Janmey
Paul B Savage
Robert Bucki
Scott Diamond
P2860
P304
P356
10.1093/JAC/DKS434
P407
P577
2012-11-07T00:00:00Z